PD-L1: an unavoidable biomarker in advanced triple-negative breast cancer

被引：9
|
作者：
Akiki, Mira [1 ]
Haddad, Fady Gh [2 ]
Kourie, Hampig Raphael [2 ]
Khaddage, Abir [1 ]
Smayra, Viviane Track [1 ]
机构：
[1] St Joseph Univ, Fac Med, Pathol Dept, Beirut, Lebanon
[2] St Joseph Univ, Fac Med, Hematol & Oncol Dept, Beirut, Lebanon
来源：
BIOMARKERS IN MEDICINE | 2019年 / 13卷 / 18期
关键词：
breast cancer; clinical trials; immunotherapy; oncology; PD-L1; TNBC; triple negative; EXPRESSION;
D O I：
10.2217/bmm-2019-0344
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：1539 / 1541
页数：3
相关论文
共 50 条
  • [1] Ferroptosis Inducers Upregulate PD-L1 in Recurrent Triple-Negative Breast Cancer
    Desterke, Christophe
    Xiang, Yao
    Elhage, Rima
    Duruel, Clemence
    Chang, Yunhua
    Hamai, Ahmed
    CANCERS, 2024, 16 (01)
  • [2] Expression of PD-L1 in triple-negative breast cancer based on different immunohistochemical antibodies
    Sun, Woo Young
    Lee, Yu Kyung
    Koo, Ja Seung
    JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [3] PD-1 Independent Role of PD-L1 in Triple-Negative Breast Cancer Progression
    Alkaabi, Duaa
    Arafat, Kholoud
    Sulaiman, Shahrazad
    Al-Azawi, Aya Mudhafar
    Attoub, Samir
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [4] PD-L1 Expression in Triple-Negative Breast Cancer
    Mittendorf, Elizabeth A.
    Philips, Anne V.
    Meric-Bernstam, Funda
    Qiao, Na
    Wu, Yun
    Harrington, Susan
    Su, Xiaoping
    Wang, Ying
    Gonzalez-Angulo, Ana M.
    Akcakanat, Argun
    Chawla, Akhil
    Curran, Michael
    Hwu, Patrick
    Sharma, Padmanee
    Litton, Jennifer K.
    Molldrem, Jeffrey J.
    Alatrash, Gheath
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (04) : 361 - 370
  • [5] Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1
    Li, Chia-Wei
    Lim, Seung-Oe
    Chung, Ezra M.
    Kim, Yong-Soo
    Park, Andrew H.
    Yao, Jun
    Cha, Jong-Ho
    Xia, Weiya
    Chan, Li-Chuan
    Kim, Taewan
    Chang, Shih-Shin
    Lee, Heng-Huan
    Chou, Chao-Kai
    Liu, Yen-Liang
    Yeh, Hsin-Chih
    Perillo, Evan P.
    Dunn, Andrew K.
    Kuo, Chu-Wei
    Khoo, Kay-Hooi
    Hsu, Jennifer L.
    Wu, Yun
    Hsu, Jung-Mao
    Yamaguchi, Hirohito
    Huang, Tzu-Hsuan
    Sahin, Aysegul A.
    Hortobagyi, Gabriel N.
    Yoo, Stephen S.
    Hung, Mien-Chie
    CANCER CELL, 2018, 33 (02) : 187 - +
  • [6] JAK2 and PD-L1 Amplification Enhance the Dynamic Expression of PD-L1 in Triple-negative Breast Cancer
    Chen, Meixuan
    Pockaj, Barbara
    Andreozzi, Mariacarla
    Barrett, Michael T.
    Krishna, Sri
    Eaton, Seron
    Niu, Ruifang
    Anderson, Karen S.
    CLINICAL BREAST CANCER, 2018, 18 (05) : E1205 - E1215
  • [7] Multiomics analysis reveals the landscape of PD-L1 expression in triple-negative breast cancer
    Wang, Han
    Ding, Xiao-Hong
    Liu, Cheng-Lin
    Xiao, Yi
    Shui, Ruo-Hong
    Li, Yan-Ping
    Chen, Chen
    Yang, Wen-Tao
    Shao, Zhi-Ming
    Jiang, Yi-Zhou
    CANCER RESEARCH, 2024, 84 (09)
  • [8] PD-L1 EXPRESSION IN TRIPLE-NEGATIVE BREAST CANCER: A CROSS-SECTIONAL STUDY IN A POLISH POPULATION
    Szylberg, Lukasz
    Antoniewicz, Ewa
    Olszewski, Wojciech
    Kowalewski, Adam
    Zdrenka, Marek
    Dziekan, Beata
    Ibbs, Matthew
    Filas, Violetta
    Marszalek, Andrzej
    POLISH JOURNAL OF PATHOLOGY, 2020, 71 (04) : 301 - 306
  • [9] Targeting PD-1/PD-L1 in cancer immunotherapy: An effective strategy for treatment of triple-negative breast cancer (TNBC) patients
    Kumar, Sunny
    Chatterjee, Mouli
    Ghosh, Pratyasha
    Ganguly, Kirat K.
    Basu, Malini
    Ghosh, Mrinal K.
    GENES & DISEASES, 2023, 10 (04) : 1318 - 1350
  • [10] Expression of PD-L1 in triple-negative breast cancer based on different immunohistochemical antibodies
    Woo Young Sun
    Yu Kyung Lee
    Ja Seung Koo
    Journal of Translational Medicine, 14
12345